CSIMarket
 


Chiasma Inc   (CHMA)
Other Ticker:  
 

Cumulative Chiasma Inc 's Quick Ratio for Trailing Twelve Months Period

CHMA's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CHMA Quick Ratio for Trailing Twelve Months Period

(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Current Liabilities Growth 29.21 % 47.09 % 91.05 % 80.33 % -52.45 %
Y / Y Cash & cash equivalent Growth 45.13 % 46.6 % 52.64 % 15.37 % 134.11 %
Quick Ratio for Trailing Twelve Months Period 6.96 6.83 6.72 6.8 7.71
Total Ranking # 490 # 418 # 375 # 370 # 305
Seq. Current Liabilities Growth 3.51 % -7.8 % 13.82 % 18.94 % 17.84 %
Seq. Cash & cash equivalent Growth -15.06 % -13.61 % 133.66 % -15.36 % -14.2 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2021
On the trailing twelve months basis Chiasma Inc Cash & cash equivalent average soared by 45.13% in I. Quarter year on year, faster than Current Liabilities, this led to increase in in Chiasma Inc 's Quick Ratio for Trailing Twelve Months Period to 6.96, Quick Ratio for Trailing Twelve Months Period remained below Chiasma Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 203 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Chiasma Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about CHMA
Quick Ratio CHMA in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 204
Sector # 306
S&P 500 # 500


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
17.2 8.15 2.41
(Mar 31 2016)   (Mar 31 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2021, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Shattuck Labs Inc   18.90 
Hoth Therapeutics Inc   18.90 
Constellation Pharmaceuticals Inc  18.75 
Lexaria Bioscience Corp   18.29 
Guardion Health Sciences Inc   18.23 
Gossamer Bio Inc   17.84 
89bio Inc   17.77 
Verona Pharma Plc  17.57 
Hepion Pharmaceuticals inc   17.39 
Arcutis Biotherapeutics Inc   17.32 
Applied Molecular Transport Inc   17.12 
Painreform Ltd  16.72 
Aadi Bioscience Inc   16.69 
Vistagen Therapeutics Inc   16.67 
Assembly Biosciences Inc   16.61 
Savara Inc   16.22 
Oragenics Inc   16.20 
Arbutus Biopharma Corp  16.01 
Nighthawk Biosciences inc   15.98 
Lixte Biotechnology Holdings Inc   15.91 
Principia Biopharma Inc   15.81 
Cocrystal Pharma Inc   15.79 
Relmada Therapeutics Inc   15.67 
Trillium Therapeutics Inc   15.65 
Werewolf Therapeutics Inc   15.64 
Prothena Corporation Public Limited Company  15.60 
Uniqure N v   15.46 
Crinetics Pharmaceuticals Inc   15.45 
Mirati Therapeutics Inc   15.40 
Inozyme Pharma Inc   15.16 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com